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2History
A 6 year old male snow leopard (Uncia uncia), [50kg] with a current vaccination history, was 
presented stumbling across thresholds with increasing frequency and severity over several weeks. 
Upon inspection, the snow leopard was bright and alert with a good general body condition, but 
was reluctant to move.  Paresis and ataxia with lack of proprioception in both hind legs were 
recognized. 
Anesthesia was induced (4.1mg/kg ketamine, Narketan®, 10 ad us. vet., Vétoquinol, 3123 Belp, 
Switzerland and  0.1mg/kg  medetomidine,  Zalopine®,  Orion  Pharma,  02101  Espoo,  Finland, 
intramuscularly) by blow pipe. The snow leopard was intubated and maintained with isoflurane 
(Attane™, Provet, 3421 Lyssach, Switzerland) in oxygen. Cardiopulmonary monitoring included 
electrocardiogram,  non-invasive  blood  pressure,  respiratory  rate,  capnography  and  pulse-
oxymetry  (Datex  Ohmeda,  Cardiocap/5,  Anandic  Medical  Systems  AG,  8253  Diessenhofen, 
Switzerland). Blood was drawn for hematology and serum biochemistry. 
Hematology results were normal against ISIS reference values4 except for a mild leukocytosis 
(20.0 x109/l), accompanied by neutrophilia (17.4 x109/l). Serum protein electrophoresis (SPE) did 
not  reveal  a  monoclonal  gammopathy.  Serum  biochemical  data  were  normal  against  ISIS 
reference  values4 except  for  the  presence  of  hyperglycemia  (17.0mmol/l  or  306mg/dl). 
Serological assays for feline immunodeficiency virus (Antibody Capture ELISA, University of 
Zürich) and feline leukemia virus (Antigen Capture ELISA, University of Zürich) were negative. 
Cerebrospinal fluid (CSF) was obtained via an atlanto-occipital and lumbar puncture with a 20G 
spinal  needle  (Terumo® Spinal  Needle,  Terumo Europe  N.V.,  3001 Leuven,  Belgium).  High 
concentrations  of protein  (2.20g/L),  leukocytes  (1cell/µl),  neutrophiles  (6%) and erythrocytes 
(40cells/µl ) were found in the lumbar cerebrospinal fluid against feline reference values.9, 10 Plain 
radiographs of the spine and myelography was performed via an atlanto-occipital  and lumbar 
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3puncture (0.4ml/kg iodine contrast media, Isovist®-240, Bayer AG, 8045 Zürich, Switzerland). 
Examine obtained results and radiographs (Fig. 1) before continuing.
Diagnosis
While the atlanto-occipital CSF was of normal clear color with a cell count within normal limits 
similar  to  domestic  cats,10 the lumbar  CSF was consistent  with a  mixed pleocytosis with an 
increased cellularity and protein content consisting of one nucleated cell/µL (reference range,10 0 
to 0.5 cells/µL). The predominant cells were neutrophils comprising 84.6% of the total number of 
cells. No organisms or atypical cells were identified. 
Plain  radiographs  of  the  spine  showed  a  poorly  defined  radiolucent  area  within  the  twelfth 
thoracic vertebral (Th 12) body (large arrow), with an interrupted vertebra base and the bilateral 
absence  of  the  peduncles  similar  to  the  myelography  pictures  (Fig.  1).  Cisternal  injection 
demonstrated  an  abrupt  ending  contrast  medium  column  at  the  caudal  end  of  the  eleventh 
thoracic vertebra (Th 11) and a lateral deviation of both columns to the left in the ventrodorsal 
view. Lumbar injection showed an apparent thinning of the dye column at the body of Th 12. 
Right lateral radiographs demonstrated a widening of the dye, while in ventrodorsal view a lateral 
deviation of both dye columns to the left were seen (small arrow). A poorly defined hypodense 
area within the body of Th 12 (large arrow), with an interrupted vertebra base and the bilateral 
absence of the peduncles was seen (Fig. 1). Radiographic diagnosis of additional lesions was 
difficult in the current case. Only the aggressive bone lesion of Th 12 was detected although 
various radiographs were taken. Only pathologic examination and histology was able to detect 
the smaller lesions in Th 13 and L2. 
Radiologic and laboratory findings were consistent with a severe extradural compressive lesion 
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4from right laterally and ventrally with aggressive bone lesion of Th 12. Neoplasia,  similar  to 
osteosarcoma, fibrosarcoma or metastatic tumor, was suspected. Due to the poor prognosis of this 
diagnosis, the snow leopard was euthanized with pentobarbital (Vetanarcol®, ad us. vet, 0.8ml/kg, 
i.v., Veterinaria AG, 8045 Zürich, Switzerland). 
Post-mortem investigation revealed in  the longitudinal  section of the vertebral  column that  a 
white soft gelatinous mass of about 2 x 2 x 2cm that displaced the bony structure of the cranio-
dorsal region of the body of Th 12 (Figure 2a, arrows). Additional blurred bordered white areas 
were found in the bone marrow of Th 13 and the second lumbal vertebra (L 2). 
The  white  mass  in  Th  12  protruded  into  the  vertebral  canal  compressing  the  spinal  cord. 
Histologic sections confirmed compression of the spinal cord at the level of Th 12 characterized 
by mild Wallerian degeneration in the white matter  of the spinal cord.  The thoracic vertebral 
masses  consisted  of  infiltrative  densely  packed  sheets  of  round  cells  which  replaced  the 
architecture of the vertebrae and bone marrow. The round cells had abundant centric to eccentric 
nuclei and mostly homogenous eosinophilic cytoplasm with distinct cell borders consistent with 
plasma cells with occasional irregular perinuclear pallor (Figure 2b). Final diagnosis of multiple 
myeloma was concluded by histopathology and immunology of the mass in Th12 according to 
the International Myeloma Working Group.1 
Discussion
Clinically,  the  animal  presented  with  progressive  ataxia  and paresis  of  his  hind legs.  Spinal 
radiographs  including  myelography  showed  an  extreme  extradural  compression  with  an 
aggressive  bone  lesion  within  Th  12.  Histopathology  and  immunohistological  investigations 
identified  the  mass  in  Th 12 as  well  as  the  other  masses  in  Th13 and L2 as  a  plasma  cell 
neoplasia  and the diagnosis  multiple  myeloma was formulated  according  to  the International 
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5Myeloma Working Group.1
Multiple  myelomas  have  been  classified  together  with  monoclonal  gammopathies  and 
plasmacytomas  as  myeloma-related  disorder  (MRD).1 Myeloma-related  disorders  are  less 
common in domestic cats than dogs and humans,5 and epidemiologic details for large felids have 
not  been  documented  previously.  The  current  case  describes  an  MRD in  a  relatively  young 
animal,  contrary to studies in domestic  cats,  where MRD occurred in older cats.12 The main 
characteristics  of  this  case  are  the  isolated  bone  lesions  in  the  vertebral  bodies.  Plasma  cell 
neoplasias are more often seen in bones responsible for active hematopoiesis.13 Nevertheless, 
MRD in domestic cats present less frequently with radiographic bone lesions than in humans, and 
extramedullary presentation  is  more  frequent.5 Common findings  in  feline  multiple  myeloma 
normally include bone lesions  and multi-organ involvement.8 In this  case characteristic  bone 
lesions with atypical plasma cell morphology were found, though visceral organ infiltration was 
missing. 
It is assumed that most cases of solitary plasmacytoma eventually progress to systemic multiple 
myelomas  similar  to  the  present  case.12 Prognosis  depends  on  the  time  of  presentation, 
localization of the neoplasm and the potential of developing metastases. While extramedullary 
plasmacytoma treatment can often be curative, plasmacytoma of bone carries a poor prognosis 
for  they  typically  progress  to  systemic  multiple  myeloma.1 Therefore,  early  detection  of 
developing metastases is crucial for treatment consideration and prognosis. Further evaluation of 
thepatient by computer tomography is strongly recommended before treatment is attempted to 
detect metastasis. 
Differing opinions exist concerning treatment options in domestic animals, while they are limited 
to  non-existent  experiences  in  exotic  felids.  In  general,  plasmacytomas  as  well  as  multiple 
myelomas are thought to be chemo- and radiosensitive.7, 11-13 The therapy of disseminated lesions 
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6is affected via melphalan, a chemotherapy drug that can be given orally as a continual therapy. 
Melphalan  combined  with  methylprednisolone  after  surgical  excision  has  shown  promising 
results in cats with solitary plasmacytoma of bone,6 while in one study, the treatment of multiple 
myelomas with melphalan and prednisolone showed complete remission in four out of eight cats.2 
Only one single case report  of a chemotherapeutic  treated big cat  was found in the research 
literature.3 However,  surgery  in  combination  with  chemotherapy  on  the  basis  of  companion 
animals and human medicine experiences could be useful in the treatment of genetically valuable 
zoo animals. 
In summary, a spinal tumor, such as solitary plasmacytoma of bone or multiple myeloma should 
be considered as a differential diagnosis for any big cat that presents with progressive hind leg 
paresis. Myelography via atlanto-occipital and lumbar puncture was very useful in visualizing the 
aggressive lesion with its compression of the spinal cord. In the future, further investigations, 
such as computer  tomography (CT), biopsy or fine-needle aspiration should be considered in 
similar cases when treatment options and prognosis are evaluated. Computer tomography should 
be part of the diagnostic plan in cases suspected to have this neoplasm for better evaluation, and 
to differentiate between solitary plasmacytoma and multiple myeloma.
     Acknowledgments:  We gratefully acknowledge the work and support of Ms. G. Hürlimann. 
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FIGURE LEGENDS
Figure 1.  Right lateral (A) and ventrodorsal (B) myelographic radiographs of the thoracolumbar 
spinal column of a 6 year old snow leopard (Uncia uncia) presented with hind leg paresis. 
Figure 2.   Gross,  longitudinal  section of the vertebral  column of a 6 year  old snow leopard 
(Uncia uncia) (A). A white, gelatinous soft mass of 2 x 2 x 2 cm with displacement of the 
bony  structure  of  the  cranio-dorsal  region  of  the  body  of  the  twelfth  vertebra.  The 
histologic  section (B) from the infiltrative growing white  mass (hematoxylin  and eosin 
stain, original magnification x1000).
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